Advertisements



Iovance Biotherapeutics provides clinical update on C-144-01, C-145-04

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Mid-Day Market Update: EXFO Falls After Q4 Results; Iovance Biotherapeutics Shares Climb

Midway through trading Friday, the Dow traded up 0.80 percent to 25,252.55 while the NASDAQ climbed 1.82 percent to 7,462.44. The S&P also rose, gaining 1.14 percent to 2,759.37. read more.....»»

Category: blogSource: benzingaOct 12th, 2018

Iovance Biotherapeutics announces clinical trial updates with collaborators

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results

WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today prov.....»»

Category: earningsSource: benzingaMay 10th, 2018

Orgenesis subsidiary announces services agreement with Iovance Biotherapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Iovance Biotherapeutics, MaSTherCell announce new MSA in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Iovance Biotherapeutics price target raised to $26 from $22 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Iovance Biotherapeutics 22M share spot secondary priced at $9.97

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Iovance Biotherapeutics price target raised to $25 from $22 at Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Iovance Biotherapeutics intends to sell shares in public offering

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Iovance Biotherapeutics reports results from FDA end of Phase 2 meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Iovance Biotherapeutics files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Aeglea BioTherapeutics to present new Phase 1/2 clinical trial data at ASHG

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Iovance Biotherapeutics Enters Oversold Territory

Dividend Channel.....»»

Category: topSource: redinewsSep 28th, 2018

Iovance Biotherapeutics weakness a buying opportunity, says Cowen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2018

UPDATE: Mersana Therapeutics stock leaps 4.7% after FDA lifts clinical hold on cancer therapy trial

Mersana Therapeutics Inc. said Monday t.....»»

Category: topSource: marketwatchSep 17th, 2018

Iovance Biotherapeutics files $250M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 7th, 2018

Crinetics Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on the discovery, development a.....»»

Category: earningsSource: benzingaAug 30th, 2018

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Category: earningsSource: benzingaAug 17th, 2018

IOVA Stock Is on the Cusp of a Sustained Move Toward Higher Prices

IOVA Stock: One Signal Down, One to Go Today's focus is Iovance Biotherapeutics Inc (NASDAQ:IOVA) stock. I am returning to follow up on a.....»»

Category: analysisSource: profitconfidentialAug 16th, 2018

Neuralstem Provides Business Update and Reports Second Quarter 2018 Fiscal Results

- Phase 2 clinical trial initi.....»»

Category: earningsSource: benzingaAug 15th, 2018